We identified four genes (LPL, CLDN18, EDNRB, and MME) as potential biomarkers for NSCLC in the USA cohort, and three genes EDNRB, MME, and ROBO4 as potential biomarkers for NSCLC in the Taiwan cohort. The gene discussed is LPL; the disease is non-small cell lung carcinoma.